cymbalta for depression reviews - cymbalta ulcerative colitis
tramadol taken with cymbalta <a href=http://cymbaltaprice-hn.webs.com>side effects with cymbalta</a> - dangers of quitting taking cymbalta
Limited data are available on the effects of duloxetine in patients with end-stage renal disease ESRD. After a single 60-mg dose of duloxetine, C max and AUC values were approximately 100% greater in patients with end-stage renal disease receiving chronic intermittent hemodialysis than in subjects with normal renal function. The elimination half-life, however, was similar in both groups. The AUCs of the major circulating metabolites, 4-hydroxy duloxetine glucuronide and 5-hydroxy, 6-methoxy duloxetine sulfate, largely excreted in urine, were approximately 7- to 9-fold higher and would be expected to increase further with multiple dosing. For this reason, Cymbalta is not recommended for patients with end-stage renal disease requiring dialysis or severe renal impairment estimated creatinine clearance CrCl 30 mL/min see DOSAGE AND ADMINISTRATION. Population PK analyses suggest that mild to moderate degrees of renal dysfunction estimated CrCl 30-80 mL/min have no significant effect on duloxetine apparent clearance. CYMBALTA has been evaluated for safety in 2418 patients diagnosed with major depressive disorder who participated in multiple-dose premarketing trials, representing 1099 patient-years of exposure. Among these 2418 CYMBALTA treated patients, 1139 patients participated in eight 8- or 9- week, placebo-controlled trials at doses ranging from 40 to 120 mg/day, while the remaining 1279 patients were followed for up to 1 year in an open-label safety study using flexible doses from 80 to 120 mg/day. Two placebo-controlled studies with doses of 80 to 120 mg/day had 6- month maintenance extensions. Of these 2418 patients, 993 CYMBALTA-treated patients were exposed for at least 180 days and 445 CYMBALTA-treated patients were exposed for at least 1 year. Adverse reactions were assessed by collecting adverse events, results of physical examinations, vital signs, weights, laboratory analyses, and ECGs.
ssmha, ^.^ <b>cymbalta tcas</b> best way to get off cymbalta - cymbalta prescription information
<b>cymbalta unusual bruising</b> <i>does cymbalta decrease borth control effectiveness</i>